Residency · Houston, TX
Sponsored by HCA Houston Healthcare/University of Houston
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage.
The New England journal of medicine · 2024 · 232 citations · Truman Milling
Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors.
Circulation · 2023 · 146 citations · Truman Milling
Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation: a systematic review and prospective individual participant data meta-analysis of randomised controlled trials (CATALYST).
Lancet (London, England) · 2025 · 33 citations · Truman Milling
Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation: A Pragmatic, Response-Adaptive Randomized Clinical Trial.
JAMA neurology · 2025 · 27 citations · Truman Milling
Prospective Observational Cohort Study of Tenecteplase Versus Alteplase in Routine Clinical Practice.
Stroke · 2022 · 57 citations · Truman Milling
Hemostatic Efficacy and Anti-FXa (Factor Xa) Reversal With Andexanet Alfa in Intracranial Hemorrhage: ANNEXA-4 Substudy.
Stroke · 2021 · 55 citations · Truman Milling
Andexanet Alfa for Specific Anticoagulation Reversal in Patients with Acute Bleeding during Treatment with Edoxaban.
Thrombosis and haemostasis · 2022 · 34 citations · Truman Milling
Long-Term Safety of a Four-Factor Prothrombin Complex Concentrate (Kcentra®/Beriplex® P/N): An Updated Pharmacovigilance Review.
Thrombosis and haemostasis · 2025 · 8 citations · Truman Milling